Top compounds associated with response to HS3ST2


Feature Type Standardized
Nominal ANOVA
mRNA FMK GDSC1000 pan-cancer AAC -0.075 0.04
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.073 0.04
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC 0.077 0.04
mRNA Erlotinib CCLE pan-cancer AAC 0.092 0.04
mRNA Bortezomib GDSC1000 pan-cancer AAC -0.1 0.04
mRNA tigecycline CTRPv2 pan-cancer AAC 0.096 0.04
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.076 0.04
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.071 0.04
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.11 0.05
mRNA QL-VIII-58 GDSC1000 pan-cancer AAC -0.09 0.05
Download CSV